United Therapeutics | UTHR - Sales Revenues


United Therapeutics reported $783.3M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Amarin USD 49.22M 451K Dec/2025
Ardelyx USD 94.47M 30.74M Mar/2026
Baxter International USD 2.96B 260M Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
BioCryst Pharmaceuticals USD 218.25M 188.3M Jun/2026
Biogen USD 2.74B 490M Jun/2026
BioMarin Pharmaceutical USD 990M 224M Jun/2026
Emergent BioSolutions USD 276.6M 6.1M Dec/2023
Gilead Sciences USD 7.8B 800M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Halozyme Therapeutics USD 481M 104M Jun/2026
Insmed USD 425.49M 119.53M Jun/2026
Ionis Pharmaceuticals USD 268M 22M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Lexicon Pharmaceuticals USD 5.49M 8.69M Dec/2025
Moderna USD 100M 289M Jun/2026
Pfizer USD 15.03B 530M Jun/2026
PTC Therapeutics USD 361M 88M Jun/2026
Regeneron Pharmaceuticals USD 4.29B 690M Jun/2026
Sangamo BioSciences USD 356K 125K Jun/2024
Sarepta Therapeutics USD 401.3M 329.5M Jun/2026
Teva Pharmaceutical Industries USD 12.67B 900M Jun/2026
United Therapeutics USD 783.3M 1.8M Jun/2026
Vertex Pharmaceuticals USD 3.33B 340M Jun/2026